$16.68
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
QDEL: Lowering target price to $13.00
Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway
QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Overview
52-week range
$9.92
$36
26% of range
Avg surprise (last 2)
-40.5%
Avg reaction (last 2)
-3.2%
0% positive
Latest IV / EM
126%
EM ±28.7% · $18 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $-0.04 | $0.37 | -110.8% | -105.4% | -6.1% | earnings |
| Sun Sep 28, 2025 | Sep 2025 | $-10.78 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.12 | — | — | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.74 | $0.57 | +29.8% | — | -0.3% | earnings |
| Sun Sep 29, 2024 | Sep 2024 | $-0.30 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-2.20 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-25.50 | — | — | — | — | financials |
| Sun Oct 1, 2023 | Oct 2023 | $-0.19 | — | — | — | — | financials |
| Sun Jul 2, 2023 | Jul 2023 | $-0.80 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | -$0.04 | $0.12 | -133.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $620M | — | $700M | $614M | $693M | — | $727M | $637M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-32M | — | $-705M | $-181M | $33M | — | $15M | $-118M |
| Net income | $-92M | — | $-733M | $-255M | $-13M | — | $-20M | $-148M |
| EPS (diluted) | $-1.35 | — | $-10.78 | $-3.77 | $-0.19 | — | $-0.30 | $-2.20 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $140M | $170M | $98M | $152M | $127M | $98M | $144M | $107M |
| Inventory | $612M | $578M | $614M | $579M | $563M | $534M | $577M | $602M |
| Total current assets | $1.38B | $1.45B | $1.37B | $1.28B | $1.26B | $1.22B | $1.41B | $1.34B |
| Total assets | $5.63B | $5.77B | $5.68B | $6.38B | $6.46B | $6.42B | $6.80B | $6.69B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3.78B | $3.85B | $3.64B | $3.59B | $3.46B | $3.44B | $3.61B | $3.52B |
| Total equity | $1.85B | $1.92B | $2.04B | $2.79B | $3.00B | $2.98B | $3.19B | $3.17B |